Metadoxine in the treatment of acute and chronic alcoholism: A review

International Journal of Immunopathology and Pharmacology

Volumn 16, Issue 3, 2003, Pages 207-214

  Addolorato, Giovanni ^a   Ancona, C ^a   Capristo, E ^a   Gasbarrini, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute and chronic alcohol intoxication; Alcoholism; Metadoxine

Indexed keywords

2 OXOGLUTARIC ACID; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; DRUG METABOLITE; GLUTAMIC ACID; GLUTAMINE; GLUTAMYLCYSTEINE; GLUTATHIONE; METADOXINE; MULTIVITAMIN; NEUROLEPTIC AGENT; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXINE; PYROGLUTAMIC ACID; UNCLASSIFIED DRUG;

ABSTINENCE; ALCOHOL ABUSE; ALCOHOL INTOXICATION; ALCOHOLISM; CLINICAL TRIAL; DIARRHEA; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; ENZYME ACTIVITY; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER INJURY; MAINTENANCE THERAPY; NONHUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PSYCHOPATHY; REVIEW; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

EID: 3543048041     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200301600304     Document Type: Review

References (60)

1. Schuckit M.A. 1986. Genetic and clinical implications of alcoholism and affective disorders. Am. J. Psychiatry 143:140.
2. Schukit M.A. and E.O. Gold. 1988. A simultaneous evaluation of multiple markers of ethanol/placebo challenges in sons of alcoholics and controls. Arch. Gen. Psychiatry 45:211.
3. Lieber C.S. 1995. Medical disorders of alcoholics. N. Engl. J. Med. 333:1058.
4. Adams W.L., Z. Yuan, J.J. Barboriak and A.A. Rimm. 1993. Alcohol-related hospitalizations of elderly people. JAMA 270:1222.
5. Leevy C.M. 1962. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of literature. Medicine 41:249.
6. Addolorato G., C. Ancona and A. Gasbarrini. 2000. Role of alcohol abuse and hepatitis virus in liver cirrhosis: hypothesis on action of ethanol as a cofactor. Alcohol Res. 5:237.
7. Sudzak P.D., S.M. Paul and J.N. Crawley. 1988. Effects of RO 15-4513 and other benzodiazepines receptor inverse agonists on alcohol induced intoxication in rat. J. Pharmacol. Exp. Ther. 245:880.
8. Imperato A. and G. Di Chiara. 1986. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exl. Ther. 239:219.
9. Branchey L., M. Branchey, D. Zucher, S. Shaw and C.S. Lieber. 1985. Association between low plasma tryptophan and blackouts in male alcoholic patients. Alcoholism 9:393.
10. Woodward J.J. and R.A. Gonzales. 1990. Ethanol inhibition of N-methyl-D-aspartate-stimulated endogenous dopamine release from rat striatal slices reverse by glucine. J. Neurochem. 54:712.
11. Andreasson S., P. Allebeck and A. Romelsjic. 1988. Alcohol and mortality among young men; longitudinal study of Swedish conscripts. Br. Med. J. 296:1021.
12. Addolorato G., A. Armuzzi and G. Gasbarrini. 2002. Pharmacological approaches to the management of alcohol addiction. Eur. Rev. Med. Pharmacol. Sci. 6:89.
13. Wilk S. and M. Orlowski. 1973. The occurrence of free L-pyrrolidone carboxylic in body fluids and tissues. Febs Lett. 12:157.
14. Annoni G., L. Contu and M.A. Tronci. 1992. Pyridoxol 1, 2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCL4-treated rats. Pharmacol. Res. 25:87.
15. Shull K.H. and R. Kisilevsky. 1971. Effects of L-2-Pyrrolidone-5- carboxylate on hepatic adenosine triphosphate levels in the ethionine treated rat. Biochem. Pharmacol. 20:2781.
16. Lumenhs L. 1978. The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal's-5-phosphate metabolism. J. Clin. Invest. 62:286.
17. Felicioli R., I. Saracchi and A.M. Flagiello. 1980. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats. Int. J. Clin. Pharm. Ther. Toxicol. 18:277.
18. Izquierdo I. and J. Tonent. 1989. Bioequivalence study of two metadoxine formulations in healthy volunteers. Proc. Int. Congress. "Personality and psychopathology", Pisa, p. 48.
19. Segre G. 1979. Kinetics of metadoxine in rat, dog and monkey after intravenous and oral administration. In: Report from the Institute of Pharmacology. University of Siena, Italy, p. 1.
20. Matera M. and U. Scapagnini. 1981. Kinetics of absorption and distribution of metadoxine. In: Report from the Institute of Pharmacology. University of Catania, Italy, p. 1.
21. Rizza V. and U. Scapagnini. 1981. Pharmacokinetics and bioavailability of metadoxine in rat animal model. In: Report from the Institute of Pharmacology. University of Catania, Italy, p. 1.
22. Calabrese V., N. Ragusa and V. Rizza. 1995. Effects of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during ethanol intake in rats. Int. J. Tiss. React. 17:15.
23. Parè X., A. Moreno and J.M. Peralba. 1991. Action of metadoxine on isolated human and rat alcohol and aldehyde dehydrogenases. Effect on enzymes in chronic ethanol fed rats. Met. Find. Exp. Clin. Pharm. 13:37.
24. Calabrese V., G. Bombaci, A. Calderone and V. Rizza. 1993. Effects of metadoxine on cellular free fatty acid levels in ethanol treated rats. Int. J. Tiss. React. 15:235.
25. Calabrese V., A.S. Calderone, N. Ragusa and V. Rizza. 1995. Effects of metadoxine on cellular formation of fatty acid ethyl esters in ethanol treated rats. Int. J. Tiss. React. 17:101.
26. Calabrese V., E. de Bernardinis and V. Rizza. 1986. Ruolo della Metadoxina nel controllo dello stress ossidativo da intossicazione etanolica acuta e cronica. Boll. Soc. It. Biol. Sper. 62:1357.
27. Calabrese V., A. Calderone and N. Ragusa. 1996. Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats. Drugs Exp. Clin. Res. 22:17.
28. Calabrese V., G. Randazzo, N. Ragusa and V. Rizza. 1988. Long-term ethanol administration enhances age-dependent modulation of redox state in central and peripheral organs of rat: protection by metadoxine. Drugs Exp. Clin. Res. 24:85.
29. Gutierrez-Ruiz M.C., L. Bucio and A. Correa. 2001. Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture. Pharmacol. Res. 44:431.
30. Arosio B., D. Santambrogio and N. Gagliano. 1993. Changes in expression of the albumin, fibronectin and type 1 procollagen genes in CCL4-induced liver fibrosis: effect of pyridoxol L,2-pyrrol idon-5 carboxylate. Pharmacol. Toxicol. 73:301.
31. Antonelli T., V. Carla and L. Lambertini. 1984. Pyroglutamic acid administration modifies the electrocorticogram and increase of acetylcholine and GABA from the guinea-pig cerebral cortex. Pharmacol. Res. Commun. 16:189.
32. Fornai F., M.G. Alessandri and U. Bonuccelli. 1993. Effect of Metadoxine on striatal dopamine levels in C57 black mice. J. Pharm. Pharmacol. 45:476.
33. Beni M., D.E. Pellegrini Gimpietro and F. Moroni. 1988. A new endogenous anxiolytic agent: L-pyroglutamic acid. Fundam. Clin. Pharmacol. 2:77.
34. Pellegrini Giampietro D.E. and F. Moroni. 1989. Pyrrolidone carboxylic acid in acute and chronic alcoholism: preclinical and clinical studies. Rec. Prog. Med. 80:160.
35. Garau B., F. Fadda and F. Melis. 1992. Metadoxine (pyrrolidone carboxylate of pyridoxine) antagonizes the locomotor-stimulatory effect of ethanol in mice. Alcohol. 27:501.
36. Di Ilio C., G. Del Boccio and A. Arduini. 1982. Effetto della Metadoxina sull'alcolemia e sui livelli ematici di alcuni enzimi dopo ingestione di alcol. Ter. Essenz. Clin. 12:803.
37. Pellegrini-Giampietro D.E., F. Moroni and A. Pistelli. 1989. Pyrrolidone Carboxylic acid in acute and chronic alcoholism. Preclinical and Clinical studies. Rec. Prog. Med. 80:160.
38. Calabrese V., S. Carlino and V. Chinnici. 1986. La Metadoxina modula le cinetiche di assorbimento, metabolismo ed eliminazione dell'etanolo. Alcologia 5:44.
39. Bernik V., C.B. Masei and P.D. Katz. 1982. Impiego della Metadoxina in casi di intossicazione alcoolica acuta. Rassegna Int. Clin. Ter. 62:728.
40. Moroni F., E. Masini and D.E. Pellegrini-Giampietro. 1987. Preclinical pharmacology of pyrrolidone carboxylate of pyridoxine (metadoxine). In: Int. Symp. Neurotoxicology. Torino, p. 89.
41. Laprevote-Heuilly M.C. and A. Larcan. 1981. Traitement par la Metadoxine des intoxications éthyliques aigües. Ann. Med. Nancy. Est. 20:699.
42. Santoni S., P. Corradini and M. Zocchi. 1989. La Metadoxina nella patologia alcol-correlata. Clin Ter. 130:115.
43. Diaz-Martinez M.C., A. Diaz-Martinez, V. Villamil-Salcedo and C. Cruz-Fuentes. 2002. Efficacy of metadoxine in the management of acute alcohol intoxication. J. Int. Med. Res. 30:44.
44. Weber F.R., J.L. Ibarrola-Calleja and M.M. Gonzales-Jaregut. 2003. Acute metadoxine treatment for acute alcohol intoxication in an Emergency Unit. In: Intensive Care Medicine (in press).
45. Shpilenya L.S., A.P. Muzychenko, G. Gasbarrini and G. Addolorato. 2002. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study. Alcohol. Clin. Exp. Res. 26:340.
46. Bono G., E. Sinforiani and P. Merlo. 1991. Alcoholic abstinence syndrome: short-term treatment with Metadoxine. Int. J. Clin. Pharm. Res. 11:35.
47. Koch M.M., G.E. Bazuro and F. Del Sette. 1989. L'approccio al paziente alcolista in un ambulatorio di gastroenterologia: il possibile ruolo di un nuovo farmaco GABA agonista. Alcologia 1:127.
48. Rizzo A., A. Breda and M. Moretto. 1993. Uso terapeutico della metadoxina nell'alcolismo cronico. Clin. Ther. 142:243.
49. Stefanini G.F., G. Addolorato, F. Caputo and G. Gasbarrini. 1999. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function? J. Hepatol. 30:739.
50. Feliciani C., A. Verrotti, G. Coscione, P. Toto, F. Morelli, A. Di Benedetto, C. Salladini, F. Chiarelli and A. Tulli. Skin reactions due to antiepileptic drugs: several case-reports with long-term follow-up. Int. J. Immunopathol. Pharmacol. 16:89.
51. Huang S.H., F. Gambi, F. Conti, G. Carratelli, C.M.V. Conti, I. Mastromauro, G. Riccioni, A. Grilli, U. Bellati and R. Doyle. Antiepileptic drugs lower contraceptive sex hormone and increase the risk of unplanned pregnancies in women with epilepsy: revisited study. Int. J. Immunopathol. Pharmacol. 16:181.
52. Carboni M.A. and R. Corsa. 1987. Uso terapeutico della Metadoxina nei disturbi psichici e comportamentali alcool-correlati. Clin. Ther. 123:469.
53. Sinforiani E., M. Mauri and P. Merlo. 1990. Effects of Metadoxine on the early phase of cognitive recovery in abstinent alcoholics. Clin. Trials J. 27:103.
54. Corsini G., E. Gelso and G. Giuliano. 1992. Effetti della Metadoxina sulle principali alterazioni bio-umorali indotte dall'etilismo cronico. Clin. Ther. 140:251.
55. Caballeira J., A. Pares and C. Bru. 1998. Metadoxine accelerates fatty liver recovery in alcoholic patients: result of a randomized double-blind, placebo-control trial. J. Hepatol. 28:54.
56. Annoni G., B. Khlat and P. Lampertico. 1988. Metadoxine (Metadoxil*) in alcoholic liver diseases. Clin. Trials J. 25:333.
57. Intaschi G., L. Lattanzi and G. Lombardi. 1989. Gli effetti della Metadoxina nella dipendenza da alcool: implicazioni per lo studio dei rapporti tra alcolismo e depressione. In: Atti del XXXVII congresso della Soc. It. Psichiatria. Roma, p. 1.
58. Sang-Hoon P., Y. Jong-Eun and B. Kwan-Soo. 1998. An efficacy evaluation of the oral Metadoxine administration in Korean alcoholic liver patients: a randomized, placebo-controlled trial. Kor. J. Clin. Pharmacol. Ther. 6:134.
59. Sergiacomo L., R. Ciancaglini and D. Orlando. 1986. Trattamento dell'epatosteatosi alcolica con metadoxina. Risultati preliminari sulla valutazione dell'effetto del farmaco medianto studio ultrasonografico. Clin. Ther. 119:133.
60. Cacciatore L., M. Lingetti and M. Talarico M. 1986. Prime esperienze sull'efficacia della metadoxina nella steatosi epatica correlata all'abuso di alcol. Rif. Med. 101:421.